- Opportunistic salpingectomy in the Netherlands
-
Tamussino
- KMID: 2429585
- J Gynecol Oncol.
- 2019 Jan;30(1):e33.
- doi: 10.3802/jgo.2019.30.e33
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Peritoneal cancer index in ovarian cancer
-
Shin W, Park SY, Lim MC
- KMID: 2429583
- J Gynecol Oncol.
- 2019 Jan;30(1):e14.
- doi: 10.3802/jgo.2019.30.e14
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Tailoring radicality in early cervical cancer: how far can we go?
-
van der Velden J, Mom CH
- KMID: 2429584
- J Gynecol Oncol.
- 2019 Jan;30(1):e30.
- doi: 10.3802/jgo.2019.30.e30
Today, the patient who is diagnosed with early cervical cancer is offered a variety of treatments apart from standard therapy. Patients can be treated with a less radical hysterectomy (RH)... -
- CITED
-
- Close
- SHARE
-
- Close
- The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
-
Bogani G, Leone Roberti Maggiore U, Paolini B, Diito A, Martinelli F, Lorusso D, Raspagliesi F
- KMID: 2429573
- J Gynecol Oncol.
- 2019 Jan;30(1):e4.
- doi: 10.3802/jgo.2019.30.e4
OBJECTIVE: To examine outcomes of patients having treatments for newly diagnosed advanced stage low-grade serous ovarian cancer (LGSC). METHODS: We conducted a retrospective case series of women affected by advanced stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
-
Lim MC, Won YJ, Ko MJ, Kim M, Shim SH, Suh DH, Kim JW
- KMID: 2429586
- J Gynecol Oncol.
- 2019 Jan;30(1):e38.
- doi: 10.3802/jgo.2019.30.e38
OBJECTIVE: To investigate the incidence and trends of cervical (C53), endometrial (C54.1), and ovarian cancer (C56) among Korean females between 1999 and 2015. METHODS: The incidence of the three major gynecological... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis
-
Choi KH, Lee SW, Yu M, Jeong S, Lee JW, Lee JH
- KMID: 2429570
- J Gynecol Oncol.
- 2019 Jan;30(1):e1.
- doi: 10.3802/jgo.2019.30.e1
OBJECTIVE: There is no definitive guideline for the significance and cut-off value of squamous-cell carcinoma antigen (SCC-Ag) in cervical cancer. Thus, we analyzed the significance and optimal cut-off value of... -
- CITED
-
- Close
- SHARE
-
- Close
- A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma
-
Takahashi , Yunokawa M, Sasada S, Takehara Y, Miyasaka N, Kato T, Tamura K
- KMID: 2429577
- J Gynecol Oncol.
- 2019 Jan;30(1):e8.
- doi: 10.3802/jgo.2019.30.e8
OBJECTIVE: To develop and validate a 3-year recurrence prediction score (RPS) system for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma. METHODS: We reviewed 427 patients with International... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey
-
Steenbeek , van Lieshout LAM, Aarts JW, Piek JM, Coppus SF, Massuger L, Hermens RP, de Hullu J
- KMID: 2429571
- J Gynecol Oncol.
- 2019 Jan;30(1):e2.
- doi: 10.3802/jgo.2019.30.e2
OBJECTIVE: To explore current practice and influencing factors on adoption of the opportunistic salpingectomy (OS), particularly regarding the decision making, to eventually enhance the development and implementation of clear guidelines. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and dosimetry analysis of image-guided radioactive ¹²âµI seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy
-
Qu A, Jiang P, Sun H, Jiang W, Jiang Y, Tian S, Wang J
- KMID: 2429578
- J Gynecol Oncol.
- 2019 Jan;30(1):e9.
- doi: 10.3802/jgo.2019.30.e9
OBJECTIVE: To investigate the efficacy of image-guided radioactive 125I seed (IGRIS) implantation for pelvic recurrent cervical cancer (PRCC) after external beam radiotherapy (EBRT), and analyze the influence of clinical and... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
-
Kim J, Chang Y, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH
- KMID: 2429580
- J Gynecol Oncol.
- 2019 Jan;30(1):e11.
- doi: 10.3802/jgo.2019.30.e11
OBJECTIVE: Elderly age is one of the poor prognostic factors in epithelial ovarian cancer (EOC), but the optimal age cut-off is not known. The present study sought to identify the... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma
-
Lin Y, Zhou J, Cao L, Xu Q, Hao J, Zhao L, Wang J
- KMID: 2429581
- J Gynecol Oncol.
- 2019 Jan;30(1):e12.
- doi: 10.3802/jgo.2019.30.e12
OBJECTIVES: To investigate the distribution of serum calcium and the relationship between serum calcium and serum metabolic parameters in endometrial carcinoma (EC) patients. METHODS: Retrospective assessment of patients diagnosed with endometrial... -
- CITED
-
- Close
- SHARE
-
- Close
- Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
-
Kobayashi , Banno K, Kunitomi H, Tominaga E, Aoki D
- KMID: 2429579
- J Gynecol Oncol.
- 2019 Jan;30(1):e10.
- doi: 10.3802/jgo.2019.30.e10
Ovarian cancer is the seventh most common cancer and the eighth most common cause of cancer mortality in women. Although standard chemotherapy is the established treatment for ovarian cancer, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis
-
Ye Q, Cheng J, Ye M, Liu D, Zhang Y
- KMID: 2429574
- J Gynecol Oncol.
- 2019 Jan;30(1):e5.
- doi: 10.3802/jgo.2019.30.e5
OBJECTIVE: To investigate the association between pre-treatment thrombocytosis and prognosis in patients with ovarian cancer (OC). METHODS: PubMed, EMBASE, and the Cochrane Library were searched for articles regarding the prognosis of... -
- CITED
-
- Close
- SHARE
-
- Close
- Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
-
Lee YJ, Lee JY, Cho MS, Nam EJ, Kim SW, Kim S, Kim YT
- KMID: 2429572
- J Gynecol Oncol.
- 2019 Jan;30(1):e3.
- doi: 10.3802/jgo.2019.30.e3
OBJECTIVES: We conducted a protocol-based cohort study to evaluate the outcomes of interval debulking surgery (IDS) followed by paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of advanced-stage ovarian cancer. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients
-
Di Donato , Page Z, Bracchi C, Tomao F, Musella A, Perniola G, Panici PB
- KMID: 2429575
- J Gynecol Oncol.
- 2019 Jan;30(1):e6.
- doi: 10.3802/jgo.2019.30.e6
OBJECTIVE: To evaluate the impact of age-adjusted Charlson comorbidity index (ACCI) in predicting disease-free survival (DFS), overall survival (OS), and cancer-specific survival (CSS) among surgically treated patients with vulvar carcinoma.... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
-
Yoneoka Y, Yoshida H, Ishikawa M, Shimizu H, Uehara T, Murakami T, Kato T
- KMID: 2429576
- J Gynecol Oncol.
- 2019 Jan;30(1):e7.
- doi: 10.3802/jgo.2019.30.e7
OBJECTIVE: Gynecologists occasionally encounter synchronous endometrial and ovarian endometrioid carcinoma (SEO-EC) patients who show favorable prognosis than locally advanced or metastatic disease patients. This study aimed to elucidate prognostic factors... -
- CITED
-
- Close
- SHARE
-
- Close
- The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification
-
Guan J, Xie L, Luo X, Yang B, Zhang H, Zhu Q, Chen X
- KMID: 2429582
- J Gynecol Oncol.
- 2019 Jan;30(1):e13.
- doi: 10.3802/jgo.2019.30.e13
OBJECTIVES: Although patients with grade I and II endometrioid endometrial adenocarcinoma (EEA) are considered with good prognosis, among them 15%–25% died in 5 years. It is still unknown whether integrating... -
- CITED
-
- Close
- SHARE
-
- Close
